Platelets, Cardiac Valves and Sulphinpyrazone

• References

• 1 Ludlam CA, Allan N, Blandford RB, Dowdle R, Bentley NJ, Bloom AL. Platelet and coagulation function in patients with abnormal cardiac valves treated with Sulphinpyrazone. Thromb Haemostas 1981; 46: 743-746
• 2 Blackburn EK. Long-term anticoagulant therapy. Prescribers’ J 1976; 16: 73-74
• 3 Barkhan P. Therapeutic range with BCTR (letter). Thromb Haemostas 1976; 35: 751
• 4 Loeliger EA. The optimal therapeutic range in oral anticoagulation. History and Proposal. Thromb Haemostas 1979; 42: 1141-1152
• 5 Steele P, Rainwater J. Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease. Circulation 1980; 62: 462-465
• 6 Loeliger EA. Sulfinpyrazone and Thromboembolism (letter). Circulation 1981; 64: 1076-1077